Alan C. Herman is CSO at Coherus BioSciences, Inc. (CHRS). They have made 21 open-market trades across 1 company since 2015, most recently 2017-12-15.
CIK 0001512762
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 21 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CHRS | 50,460 | $43K |
Shares reported on the most recent Form 4, priced at the 2017-12-19 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CHRS | SELL | 2017-08-08 | 2017-08-10 | $15.02 | $527K | +19.0% | +6.0% | -5.0% |
| CHRS | SELL · 10b5-1 | 2017-07-05 | 2017-07-07 | $15.00 | $9K | +2.2% | -7.1% | +4.9% |
| CHRS | SELL | 2017-06-01 | 2017-06-05 | $20.26 | $424K | -30.8% | -33.8% | -33.3% |
| CHRS | SELL | 2017-05-01 | 2017-05-03 | $20.00 | $227K | +12.2% | +14.5% | -34.7% |
| CHRS | SELL | 2017-04-03 | 2017-04-05 | $20.73 | $470K | -1.5% | +1.0% | -26.3% |
| CHRS | SELL | 2017-03-01 | 2017-03-03 | $24.19 | $548K | -10.7% | -20.0% | -15.3% |
| CHRS | SELL | 2017-02-01 | 2017-02-03 | $27.37 | $620K | -16.0% | -8.7% | -28.9% |
| CHRS | SELL | 2017-01-03 | 2017-01-05 | $27.94 | $317K | -8.8% | -3.4% | -30.1% |
| CHRS | SELL | 2016-12-01 | 2016-12-05 | $27.46 | $535K | -2.1% | +2.5% | -12.5% |
| CHRS | SELL | 2016-11-01 | 2016-11-03 | $27.53 | $624K | +4.4% | +3.1% | -0.4% |
| CHRS | SELL | 2016-10-03 | 2016-10-05 | $25.70 | $291K | +13.7% | +10.8% | +10.2% |
| CHRS | SELL | 2016-10-03 | 2016-10-05 | $25.70 | $582K | +13.7% | +10.8% | +10.2% |
| CHRS | SELL | 2016-09-01 | 2016-09-06 | $29.99 | $1.0M | +2.4% | -16.5% | -6.9% |
| CHRS | SELL | 2016-08-01 | 2016-08-03 | $25.54 | $289K | +7.8% | +10.4% | -0.4% |
| CHRS | SELL | 2016-08-01 | 2016-08-03 | $25.54 | $579K | +7.8% | +10.4% | -0.4% |
| CHRS | SELL | 2016-07-01 | 2016-07-05 | $16.89 | $144K | +42.4% | +69.4% | +53.5% |
| CHRS | SELL | 2016-06-01 | 2016-06-03 | $18.67 | $159K | -10.3% | -9.1% | +63.6% |
| CHRS | SELL | 2016-05-02 | 2016-05-04 | $19.16 | $152K | -13.5% | -2.8% | +45.3% |
| CHRS | SELL | 2016-04-01 | 2016-04-06 | $21.29 | $160K | -6.5% | -18.4% | -29.2% |
| CHRS | SELL | 2016-03-01 | 2016-03-03 | $15.31 | $192K | +1.3% | +22.5% | +4.8% |
| CHRS | SELL · 10b5-1 | 2016-02-05 | 2016-02-09 | $15.02 | $30K | +14.2% | +40.8% | +50.2% |
| CHRS | SELL | 2016-01-04 | 2016-01-06 | $21.53 | $98K | -17.8% | -22.0% | +23.1% |
| CHRS | SELL | 2016-01-04 | 2016-01-06 | $21.40 | $85K | -17.8% | -22.0% | +23.1% |
| CHRS | SELL · 10b5-1 | 2015-12-01 | 2015-12-02 | $29.49 | $334K | -37.4% | -6.3% | -33.2% |
| CHRS | SELL · 10b5-1 | 2015-11-02 | 2015-11-04 | $28.71 | $529K | -37.4% | -6.3% | -41.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.